Literature DB >> 11081168

Confusion in clinical laboratory GH and IGF-I reports.

S Melmed.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081168     DOI: 10.1023/a:1009904031687

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


× No keyword cloud information.
  7 in total

1.  Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.

Authors:  A L Barkan; I Halasz; K J Dornfeld; C A Jaffe; R D Friberg; W F Chandler; H M Sandler
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

2.  Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.

Authors:  A Abosch; J B Tyrrell; K R Lamborn; L T Hannegan; C B Applebury; C B Wilson
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

Review 3.  Current treatment guidelines for acromegaly.

Authors:  S Melmed; I Jackson; D Kleinberg; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

4.  An audit of outcome of treatment in acromegaly.

Authors:  A S Bates; W Van't Hoff; J M Jones; R N Clayton
Journal:  Q J Med       Date:  1993-05

5.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

6.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

7.  Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.

Authors:  P U Freda; K D Post; J S Powell; S L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.